Kiromic BioPharma (NASDAQ:KRBP) Trading Down 6.1%

Kiromic BioPharma, Inc. (NASDAQ:KRBP) shares dropped 6.1% during mid-day trading on Tuesday . The company traded as low as $1.69 and last traded at $1.69. Approximately 1,903 shares were traded during trading, a decline of 66% from the average daily volume of 5,564 shares. The stock had previously closed at $1.80.

Kiromic BioPharma Price Performance

The business’s 50-day moving average price is $1.93 and its 200 day moving average price is $2.39. The firm has a market capitalization of $2.61 million, a price-to-earnings ratio of -0.17 and a beta of 1.97.

Kiromic BioPharma (NASDAQ:KRBP) last issued its quarterly earnings results on Friday, August 9th. The company reported ($0.74) earnings per share (EPS) for the quarter.

About Kiromic BioPharma

Kiromic BioPharma, Inc, a clinical stage biotherapeutics company, utilizes engineered and non-engineered Gamma Delta T cell (GDT) technologies to develop therapies for solid tumors. The company develops Deltacel-01, which is in Phase 1 clinical trial, for patients with non-small cell lung cancer; Isocel in combination with low-dose radiation to treat Mesothelin Isoform 2 positive solid malignancies; ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; Procel in combination with low-dose radiation to treat PD-L1 positive solid malignancies; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1.